Award recordCONTRACT

ADVANCED ACCELERATOR APPLICATIONS USA INC

PIID 36C25724F0058· VHA· 257-NETWORK CONTRACT OFFICE 17 (36C257)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $2,380,078 net obligations· UEI JNM4NBNHFE66· NY

Description

LUTETIUM (LU177) DOTATATE: QTY 8 LUTETIUM (LU177) PSMA: QTY 63 - DE-OB EXCESS FUNDS

Base award description: LUTETIUM (LU177) DOTATATE: QTY 20 LUTETIUM (LU177) PSMA: QTY 100

First action · last action
2024-02-06 · 2025-07-09
Transactions
3
First transaction's obligation
$4,031,438
Base + all options value (sum of deltas)
$2,380,078
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0169
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$4,031,438$0Base award · 2024-02-06 · this action $4,031,438 · running total $4,031,438Modification P00001 · 2024-03-04 · this action $0 · running total $4,031,438Modification P00002 · 2025-07-09 · this action -$1,651,360 · running total $2,380,078
  • Base2024-02-06+$4,031,438= $4,031,438
  • Mod P000012024-03-04+$0= $4,031,438
  • Mod P000022025-07-09-$1,651,360= $2,380,078
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-02-06+$4,031,438$4,031,438LUTETIUM (LU177) DOTATATE: QTY 20 LUTETIUM (LU177) PSMA: QTY 100
Mod P00001· OTHER ADMINISTRATIVE ACTION2024-03-04+$0$4,031,438LUTETIUM (LU177) DOTATATE: QTY 20 LUTETIUM (LU177) PSMA: QTY 100
Mod P00002· FUNDING ONLY ACTION2025-07-09−$1,651,360$2,380,078LUTETIUM (LU177) DOTATATE: QTY 8 LUTETIUM (LU177) PSMA: QTY 63 - DE-OB EXCESS FUNDS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JNM4NBNHFE66)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0132255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,200,000FY2026
36C26026N0121260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$996,874FY2026
36C24926N0263249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$823,062FY2026
36C25525N0282255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$166,146FY2025
36C25525N0176255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,362,395FY2025
36C25225F0044252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$631,354FY2025

Other recipients under 6505 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25726N0367ISORX TEXAS LTD257-NETWORK CONTRACT OFFICE 17 (36C257)$53,945FY2026
36C25726N0407CARDINAL HEALTH 414, LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$1,400,000FY2026
36C25726P0476PETNET SOLUTIONS, INC.257-NETWORK CONTRACT OFFICE 17 (36C257)$40,573FY2026
36C25726P0423PANHANDLE NUCLEAR RX, LTD.257-NETWORK CONTRACT OFFICE 17 (36C257)$325,038FY2026
36C25726N0316PROGENICS PHARMACEUTICALS INC257-NETWORK CONTRACT OFFICE 17 (36C257)$721,744FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25724F0058_3600_36F79719D0169_3600 · retrieved 2026-09-26.